Literature DB >> 35916973

Déjà vu All Over Again? Emergent Monkeypox, Delayed Responses, and Stigmatized Populations.

Gregg S Gonsalves1,2, Kenneth Mayer3,4,5, Chris Beyrer6.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35916973      PMCID: PMC9345008          DOI: 10.1007/s11524-022-00671-1

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   5.801


× No keyword cloud information.
Over 40 years ago, in the summer of 1981, a new illness appeared in the American gay community, with cases quickly mounting in major cities. For the first few years, the etiologic agent of what was initially called gay-related immunodeficiency syndrome was unknown, its natural history obscure, its modes of transmission uncertain, though certainly including sexual contact. What quickly became known as acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV), was spreading more widely among what was known as the “4H Club” Haitians, hemophiliacs, homosexuals, and heroin users[1]. However, along with the virus itself, blame for this new outbreak was spreading as well. Haitians were castigated for bringing the virus into the country, while homosexuals and heroin users were the focus of stigma and discrimination, with some going as far to suggest that both should be tattooed to warn partners about their infection, while a quarantine initiative appeared on the California ballot [2, 3]. The “innocent victims” of AIDS were hemophiliacs, infants infected perinatally, and those infected through exposure in healthcare settings [4]. Unlike the emergence of the atypical pneumonia among men and women attending an American Legion convention in Philadelphia in 1976, which showed up on the cover of Time magazine that year and sent the federal government into overdrive to ascertain its cause, the federal response to AIDS was lackluster at best, with the President of the USA, not even mentioning the disease until 1985 and with members of his inner circle joking about the disease [5-7]. It was largely up to the LGBTQ+ community to build its own response to the epidemic, with AIDS service organizations providing care and support to those living with the disease and policy and activist organizations arising to combat the indifference and neglect of local, state, and federal leadership [8, 9]. Furthermore, though AIDS cases among heterosexuals were documented early in Africa and elsewhere outside of the global North in the early 1980s, it took almost two decades for any international mobilization at a scale to confront the enormity of the pandemic, and marginalized populations still struggle to get adequate resources [10-13]. The early delays in the AIDS response allowed the virus to establish very high burdens globally, which have proven enormously difficult to address. As COVID-19 has taught us, the early period of epidemic spread is critical for pandemic control—and early weeks and months (or years) of inaction are terribly costly. Almost a half century later, another summer and another virus has emerged in the USA and around the globe. However, the monkeypox outbreak of 2022, now documented among close to 6000 people—the majority men who have sex with men—in over 50 countries has striking similarities and stark differences with the HIV epidemic. Both monkeypox and HIV are zoonotic infections, jumping from animal hosts into human populations, which, after two and a half years with another zoonotic pandemic of SARS-CoV2, should demonstrate to us that rather than rare occurrences, these events are likely to be more and more common in this Anthropocene epoch, when any pandemic is less than a day’s plane ride away, so that our role in planetary health drives our own risks [14]. However, unlike HIV in 1980s, monkeypox is not an unknown pathogen and has been well-described since the 1970s in Central and West Africa [15, 16]. In fact, the current global outbreak likely originated in viral strains associated with an outbreak that started in Nigeria in 2017 [17]. Furthermore, the unusual clinical and epidemiological features of this current 2022 outbreak have been seen in the Nigerian context, described by clinicians and researchers there since 2018 [18, 19]. Monkeypox also differs starkly from HIV in its early days in that we have diagnostics, vaccines, and treatments for the disease [20]. HIV and monkeypox share similarities in the global and domestic response to these diseases. The Nigerian outbreak garnered little global attention and no urgency, no mobilization by the World Health Organization to use vaccines to control the outbreak there [21]. While there have been other sporadic outbreaks of monkeypox in the global North, there has been little interest in more than local containment, and new generations of vaccines and treatments, now being scaled up for the USA and other rich countries are unavailable in Africa, and test kits are in short supply [22, 23]. Even now with worldwide dissemination of the virus, the WHO, as of June 2022, had decided that monkeypox is not a Public Health Emergency of International Concern (PHEIC), which is yet another example of the WHO failing to lead, and is hard not to interpret as indifference to the well-being of Africans, as well as gay men and our communities [24, 25]. In outbreaks, time is of the essence and are early responses to monkeypox suggest another failure of containment looms. At home in the USA, while many local, state, and federal leaders thankfully have been vocal about the need not to stigmatize monkeypox as a “gay disease,” they have been criticized for the bureaucratic delays and inaction [26-28]. In particular, the reliance on the CDC’s own laboratory response network for testing rather than scaling up to allow commercial laboratories to diagnose the disease has been challenged as a barrier to case detection by researchers, public health experts, and advocates [28, 29]. Meanwhile, the lack of global attention to monkeypox has left public health officials scrambling for doses of a key vaccine, even in the USA, while policy options to address this shortage exist [30]. Finally, LGBTQ+ and AIDS organizations—well acquainted with dealing with infectious diseases among men who have sex with men—could and must do more as well, partnering with public health officials on active surveillance, vaccination campaigns in venues frequented by gay men [31]. The real risk now is that as monkeypox continues to spread in Africa, here in the USA and the rest of the world, it becomes an endemic infection among gay and bisexual men, spreading through their dense social and sexual networks, and through multiple forms of intimate and skin to skin exposures, adding to the burdens these communities are facing already from HIV and other infectious diseases. People can spread the virus to animals as well, including wild populations (mainly rodents), so there is the possibility of establishing endemic reservoirs outside Africa, arguably for the first time. And there is a risk that without containment among gay and bisexual men, the infection can spread in other settings in which the close physical contact monkeypox requires for transmission is common, from homeless shelters and prisons to gyms and sports clubs. [32, 33], similar to outbreaks of methicillin-resistant Staphylococcus aureus, detected early in this century. However, the risk to the “general” population should not be what spurs us to act: the lives of Africans and gay men around the world should not be the canaries in the coal mine for infectious diseases like HIV or monkeypox, only useful in their function as a sentinel for the rest of us to be on our guard. Prudent and compassionate public health policies require a more rapid, engaged, and coordinated approach.
  15 in total

Review 1.  Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health.

Authors:  Sarah Whitmee; Andy Haines; Chris Beyrer; Frederick Boltz; Anthony G Capon; Braulio Ferreira de Souza Dias; Alex Ezeh; Howard Frumkin; Peng Gong; Peter Head; Richard Horton; Georgina M Mace; Robert Marten; Samuel S Myers; Sania Nishtar; Steven A Osofsky; Subhrendu K Pattanayak; Montira J Pongsiri; Cristina Romanelli; Agnes Soucat; Jeanette Vega; Derek Yach
Journal:  Lancet       Date:  2015-07-15       Impact factor: 79.321

2.  Acquired immune deficiency syndrome in Black Africans.

Authors:  N Clumeck; F Mascart-Lemone; J de Maubeuge; D Brenez; L Marcelis
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

3.  Community-based AIDS services: formalization and depoliticization.

Authors:  R Cain
Journal:  Int J Health Serv       Date:  1993       Impact factor: 1.663

Review 4.  Human monkeypox.

Authors:  Andrea M McCollum; Inger K Damon
Journal:  Clin Infect Dis       Date:  2013-10-24       Impact factor: 9.079

5.  Monkeypox: What's behind WHO's decision not to declare a public health emergency?

Authors:  Luke Taylor
Journal:  BMJ       Date:  2022-06-29

6.  A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.

Authors:  I D Ladnyj; P Ziegler; E Kima
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

7.  Human infection with monkeypox virus: laboratory investigation of six cases in West Africa.

Authors:  B Lourie; P G Bingham; H H Evans; S O Foster; J H Nakano; K L Herrmann
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

8.  The 2017 human monkeypox outbreak in Nigeria-Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria.

Authors:  Dimie Ogoina; James Hendris Izibewule; Adesola Ogunleye; Ebi Ederiane; Uchenna Anebonam; Aworabhi Neni; Abisoye Oyeyemi; Ebimitula Nicholas Etebu; Chikwe Ihekweazu
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240

9.  Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus.

Authors:  Joana Isidro; Vítor Borges; Miguel Pinto; Daniel Sobral; João Dourado Santos; Alexandra Nunes; Verónica Mixão; Rita Ferreira; Daniela Santos; Silvia Duarte; Luís Vieira; Maria José Borrego; Sofia Núncio; Isabel Lopes de Carvalho; Ana Pelerito; Rita Cordeiro; João Paulo Gomes
Journal:  Nat Med       Date:  2022-06-24       Impact factor: 87.241

10.  Reemergence of Human Monkeypox in Nigeria, 2017.

Authors:  Adesola Yinka-Ogunleye; Olusola Aruna; Dimie Ogoina; Neni Aworabhi; Womi Eteng; Sikiru Badaru; Amina Mohammed; Jeremiah Agenyi; E N Etebu; Tamuno-Wari Numbere; Adolphe Ndoreraho; Eduard Nkunzimana; Yahyah Disu; Mahmood Dalhat; Patrick Nguku; Abdulaziz Mohammed; Muhammad Saleh; Andrea McCollum; Kimberly Wilkins; Ousmane Faye; Amadou Sall; Christian Happi; Nwando Mba; Olubumi Ojo; Chikwe Ihekweazu
Journal:  Emerg Infect Dis       Date:  2018-06-17       Impact factor: 6.883

View more
  3 in total

1.  Findings on the Monkeypox Exposure Mitigation Strategies Employed by Men Who Have Sex with Men and Transgender Women in the United States.

Authors:  Randolph D Hubach; Christopher Owens
Journal:  Arch Sex Behav       Date:  2022-09-14

2.  Monkeypox virus crosstalk with HIV; where do we stand now?

Authors:  Maryam Shafaati; Milad Zandi; Om Prakash Choudhary
Journal:  Int J Surg       Date:  2022-09-09       Impact factor: 13.400

3.  Monkeypox and the legacy of prejudice in targeted public health campaigns.

Authors:  Yves Saint James Aquino; Nicolo Cabrera; James Salisi; Lee Edson Yarcia
Journal:  BMJ Glob Health       Date:  2022-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.